MacroGenics to Participate in Upcoming Investor Conferences
MacroGenics (MGNX) announced that its management team will participate in two investor conferences in November, with CEO Eric Risser giving fireside chats.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MacroGenics (MGNX) announced that its management team will participate in two investor conferences in November, with CEO Eric Risser giving fireside chats.
The Stifel 2026 Healthcare Conference chat in New York is November 11 at 10:00 am ET; the 9th Annual Evercore Healthcare Conference chat in Coral Gables is November 30 at 3:00 pm ET. Management will also hold one-on-one meetings at both events. Webcast replays will remain available for 30 days.
Details
Market Reaction – MGNX
On Nov 6, the first trading day after this news, the latest delayed price for MGNX is 9.23% above the previous close. Our momentum scanner has recorded 21 alerts for this stock so far that day. The latest delayed price is $2.42.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ROCKVILLE, MD, Nov. 05, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that the Company’s management team will participate in the following investor conferences in November:
- Stifel 2026 Healthcare Conference (New York, NY). MacroGenics’ President and CEO, Eric Risser, will participate in a fireside chat on Wednesday, November 11, at 10:00 am ET. MacroGenics’ management will also participate in one-on-one meetings.
- 9th Annual Evercore Healthcare Conference (Coral Gables, FL). Mr. Risser will participate in a fireside chat on Monday, November 30, at 3:00 pm ET. MacroGenics’ management will also participate in one-on-one meetings.
Webcasts of these presentations may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics' website at http://ir.macrogenics.com/events.cfm. The Company will maintain archived replays of the webcasts on its website for 30 days.
About MacroGenics, Inc.
MacroGenics (the Company) is a biopharmaceutical company focused on developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics’ technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please see the Company’s website at www.macrogenics.com. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.
Contacts: Jim Karrels, Senior Vice President, CFO 1-301-251-5172 info@macrogenics.com Argot Partners 1-212-600-1902 macrogenics@argotpartners.com